Current Management of Neonatal Abstinence Syndrome Secondary to Intrauterine Opioid Exposure
- 1 September 2014
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 165 (3) , 440-446
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (5T32HD069054)
This publication has 57 references indexed in Scilit:
- Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: A comparison of fetal neurobehaviors and infant outcomesDrug and Alcohol Dependence, 2012
- Neonatal abstinence syndrome: transitioning methadone-treated infants from an inpatient to an outpatient settingJournal of Perinatology, 2011
- Neonatal Abstinence Syndrome after Methadone or Buprenorphine ExposureNew England Journal of Medicine, 2010
- Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndromeAddiction, 2010
- Prenatal Methadone Exposure and Neonatal Neurobehavioral FunctioningPediatric Research, 2009
- ABM Clinical Protocol #21: Guidelines for Breastfeeding and the Drug-Dependent WomanBreastfeeding Medicine, 2009
- Sublingual Buprenorphine for Treatment of Neonatal Abstinence Syndrome: A Randomized TrialPediatrics, 2008
- The Opioid Dependent Mother and Newborn Dyad: Nonpharmacologic CareJournal of Addiction Medicine, 2008
- Genetic Variation in the Catechol-O-Methyltransferase (COMT) Gene and Morphine Requirements in Cancer Patients with PainMolecular Pain, 2008
- What is the best evidence based management of neonatal abstinence syndrome?Archives of Disease in Childhood - Fetal and Neonatal Edition, 2006